
NRG Therapeutics appoints neuroscience leader as CMO
NRG Therapeutics has announced the appointment of Dr Claus Sundgreen as Chief Medical Officer (CMO), effective from 1 August 2026. A recognised leader in neuroscience drug development with expertise in ALS, Dr Sundgreen brings over 25 years of clinical leadership with experience spanning translational medicine and all… Read More










